Cargando…
IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation
BACKGROUND: Reperfusion therapy is the most effective approach to resolve coronary occlusion, but myocardial injury caused by excessive inflammation during myocardial ischemia–reperfusion will also pose a new threat to health. Our prior study revealed the expression pattern of interleukin‐38 (IL‐38)...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266135/ https://www.ncbi.nlm.nih.gov/pubmed/37382260 http://dx.doi.org/10.1002/iid3.898 |